summari updat libr tracker report includ
preliminari data publish im week end see
updat im libr data friday preliminari im
weekli prescript data releas week end
preliminari data provid breakdown libr sensor
reader prescript separ howev reader prescript
run new libr prescript nrx
recent week estim new reader
prescript week end vs week
end week-over-week past month new
reader prescript come well-abov previou level
roughli nrx per week believ step
volum primarili reflect national-scal tv advertis
implement earli juli understand
advertis continu go forward current model
 libr sale
im recent restat rx data earlier year im restat
histor prescript data variou drugs/product
track includ libr
methodolog go forward basi updat
libr tracker align restat im number refer
im data impli reader nrx vs
previous in-lin abt commentari
import consider import note im
captur new prescript new patient thu use im
data estim new patient could overst number
patient truli new therapi believ new reader
prescript current best avail analog new libr
patient given patient need purchas one reader
remain rel earli launch reader nrx
volum remain robust worth note could see
impact come weeks/month fda approv abt
smartphon app approv given smartphon app
elimin patient need readerw suspect reader nrx
could trend lower convers understand launch
abt sensor approv result double-
count sensor nrx data despit caveat im
data continu help baromet adopt view
said would caution investor read much
weekli fluctuat nrx trend place undu relianc
data
rais price target base
adj ep estim
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
ep exclud amort intang ep continu
oper ep includ stj amo alr deal
compani data secur llc estim reuter
data week end preliminari base estim
note nrx sensor data may double-count due launch sensor
im health incorpor secur llc estim
data week end preliminari base estim
note reader nrx may impact fda approv smartphon app
im health incorpor secur llc estim
prescriptionsweek prescriptionsweek endednrx abbott laboratori
data week end preliminari base estim
im health incorpor secur llc estim
data week end preliminari base estim
note reader trx may impact fda approv smartphon app
im health incorpor secur llc estim
prescriptionsweek prescriptionsweek endedtrx medic technolog
price target
price target base ep estim risk target includ
slower growth key busi market delay stj alr integr slower margin
expect continu deliv double-digit underli ep growth mid-singl digit underli
sale growth oper leverag
abbott laboratori diversifi global medic product compani four key busi segment
nutrit diagnost establish pharmaceut epd medic devic compani report
total revenu compani acquir stj januari nearli doubl
